1. Home
  2. TBPH vs UXIN Comparison

TBPH vs UXIN Comparison

Compare TBPH & UXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • UXIN
  • Stock Information
  • Founded
  • TBPH 2013
  • UXIN 2011
  • Country
  • TBPH United States
  • UXIN China
  • Employees
  • TBPH N/A
  • UXIN N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • UXIN Business Services
  • Sector
  • TBPH Health Care
  • UXIN Consumer Discretionary
  • Exchange
  • TBPH Nasdaq
  • UXIN Nasdaq
  • Market Cap
  • TBPH 699.0M
  • UXIN 713.3M
  • IPO Year
  • TBPH N/A
  • UXIN 2018
  • Fundamental
  • Price
  • TBPH $14.58
  • UXIN $3.45
  • Analyst Decision
  • TBPH Strong Buy
  • UXIN
  • Analyst Count
  • TBPH 4
  • UXIN 0
  • Target Price
  • TBPH $23.00
  • UXIN N/A
  • AVG Volume (30 Days)
  • TBPH 367.5K
  • UXIN 260.3K
  • Earning Date
  • TBPH 11-11-2025
  • UXIN 11-24-2025
  • Dividend Yield
  • TBPH N/A
  • UXIN N/A
  • EPS Growth
  • TBPH N/A
  • UXIN N/A
  • EPS
  • TBPH 0.26
  • UXIN N/A
  • Revenue
  • TBPH $77,205,000.00
  • UXIN $340,011,237.00
  • Revenue This Year
  • TBPH $79.82
  • UXIN $727.65
  • Revenue Next Year
  • TBPH N/A
  • UXIN N/A
  • P/E Ratio
  • TBPH $56.32
  • UXIN N/A
  • Revenue Growth
  • TBPH 24.49
  • UXIN 45.02
  • 52 Week Low
  • TBPH $7.88
  • UXIN $3.13
  • 52 Week High
  • TBPH $15.15
  • UXIN $7.48
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 60.51
  • UXIN 47.26
  • Support Level
  • TBPH $14.00
  • UXIN $3.30
  • Resistance Level
  • TBPH $14.87
  • UXIN $3.94
  • Average True Range (ATR)
  • TBPH 0.50
  • UXIN 0.29
  • MACD
  • TBPH -0.02
  • UXIN 0.01
  • Stochastic Oscillator
  • TBPH 62.00
  • UXIN 26.47

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

Share on Social Networks: